#HerHealth2026: Updates in
Breast & Gynecologic
Cancer Therapeutics
Women’s Oncology Summit
Oct 9–10, 2026
10 AMA PRA Category 1 Credits10 MOC Credits (ABIM)
10 Contact Hours
AMA Conference CenterTimes Square, Manhattan
1601 Broadway, New York, NY 10019, USA
About #HerHealth2026: Updates in Breast & Gynecologic Cancer Therapeutics
#HerHealth2026: Updates in Breast & Gynecologic Cancer Therapeutics is a premier hybrid CME/CE-accredited conference dedicated to advancing clinical excellence in the prevention, diagnosis, treatment, and survivorship care of cancers affecting women. Taking place on October 9 -10, 2026, in New York City, this educational event will bring together oncologists, gynecologic oncologists, hematologist-oncologists, surgeons, primary care physicians, advanced practice providers (APPs), nurses, researchers, and other multidisciplinary healthcare professionals for an immersive learning experience focused on the rapidly evolving field of women’s oncology.
The conference will feature expert-led presentations, evidence-based clinical updates, interactive case discussions, and multidisciplinary perspectives on the latest advances in breast and gynecologic cancer care. Key educational topics will include breast cancer, ovarian cancer, endometrial cancer, cervical cancer, and rare gynecologic malignancies, with a focus on emerging treatment paradigms, biomarker-driven decision-making, precision medicine, antibody-drug conjugates (ADCs), immunotherapy, and novel targeted therapies. Attendees will also explore the growing impact of artificial intelligence, molecular diagnostics, genomic profiling, and innovative technologies that are reshaping oncology practice and improving patient outcomes.
Designed to bridge the gap between research and real-world clinical application, HerHealth2026 provides a collaborative platform for knowledge exchange, professional networking, and practical learning. Participants will gain actionable insights into current treatment challenges, evolving standards of care, and future directions in women’s oncology, helping them deliver more personalized, evidence-based care across diverse patient populations. Whether attending in person or virtually, healthcare professionals will leave equipped with the latest strategies and innovations needed to optimize outcomes for women affected by cancer.
Welcome Message from Our Chair
As Chair of #HerHealth2026: Updates in Breast & Gynecologic Cancer Therapeutics, I am pleased to invite you to join us in New York City on October 9–10, 2026, for a collaborative educational program focused on advancing the care of women with cancer.
This conference will bring together oncology specialists, researchers, and multidisciplinary healthcare professionals to review the latest clinical advances in breast cancer and gynecologic malignancies, including ovarian, endometrial, cervical, and rare gynecologic cancers. The program will highlight evolving strategies in biomarker-guided treatment selection, targeted therapies, immunotherapy, antibody-drug conjugates, and the growing role of artificial intelligence in oncology, while addressing key clinical challenges in translating emerging evidence into real-world practice.
We look forward to welcoming you to this important forum dedicated to improving clinical decision-making and outcomes for women with cancer.
Ursula A. Matulonis, MD
Conference Chair
Chief, Division of Gynecologic Oncology
Dana-Farber Cancer Institute
#HerHealth2026: Updates in Breast & Gynecologic Cancer Therapeutics is accredited by eMedEd, an approved provider of continuing medical education by the Accreditation Council for Continuing Medical Education (ACCME) and continuing education by the California Board of Registered Nursing (CBRN), offering CME for physicians and CE for nurses. This program is accredited for 10 AMA PRA Category 1 Credits™ and 10 ABIM MOC Credits for physicians and 10 contact hours for nurses.
Contact Us at contact@emedevents.com
Organized by
Marketing Partner
